Costa Rica vs Poland: HIV/AIDS deaths averted by antiretroviral therapy
Costa Rica
747.26 deaths
in 2024
Poland
683 deaths
in 2021
Costa Rica rank
83rd
Poland rank
84th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Costa Rica
- Poland
How they compare
Costa Rica currently reports 747.26 deaths against 683 deaths in Poland, a difference of 64.26 deaths.
That makes Costa Rica's figure about 1.1 times Poland's.
Across all 32 years both countries report, Poland has been ahead every year.
Costa Rica ranks 83rd and Poland ranks 84th of 157 countries.
Poland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Costa Rica | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 40.1 deaths | 40.1 deaths | Poland |
| 2000s | 162.78 deaths | 326.9 deaths | 164.12 deaths | Poland |
| 2010s | 432.26 deaths | 512.7 deaths | 80.44 deaths | Poland |
| 2020s | 610.99 deaths | 662 deaths | 51.01 deaths | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Costa Rica or Poland?
- Costa Rica, at 747.26 deaths against 683 deaths in Poland as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Costa Rica and Poland?
- 64.26 deaths, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Poland?
- 32 years are reported by both, from 1990 to 2021.
- How do Costa Rica and Poland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Costa Rica ranks 83rd and Poland ranks 84th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.